Poland· PL-100473592

Nimotop S

A nimodipine product containing nimodipinum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC C08CA06

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nimodipinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Nimodipine is registered in 14 of 19 countries.

Countries holding a registration under ATC C08CA06 (nimodipine), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search nimodipine products by name

Nimodipine · ATC C08CA06

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nimodipine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $5.28 in France to $7.99 in Switzerland — a ×1.5 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Nimodipine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$7.99
FR France$5.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Nimodipinum
Manufacturer: InPharm Sp. z o.o.
Country: Poland (PL)
ATC code: C08CA06
ATC class: Nimodipine
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 3

gtin
05909991496494
gtin
05909991496500
gtin
05909991496517

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

202 interactions on record for nimodipine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nimodipine against other medicines How interaction checks work

Nimodipine · interactions on record

202 records

15 severe
164 moderate
1 minor
20 info

Most severe, free to view

DolasetronA04AA04severe
KetoconazoleH02CA03severe
ClarithromycinJ01FA09severe
KetoconazoleJ02AB02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nimodipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nimodipine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Nimotop
Belgium · Nimotop
Bulgaria · Нимотоп S
Cyprus · Nemotan
Czechia · Dilceren, Nimotop S
Germany · Nimodipin Carinopharm, Nimodipin Ethypharm
Denmark · Nimotop
Estonia · Nimotop
Spain · Brainal, Nimodipino Altan
Finland · Nimotop
France · Nimodipine Altan, Nimotop
United Kingdom (Northern Ireland) · Nimotop
Greece · Befimat, Curban
Croatia · Nimotop S
Ireland · Nimotop
Italy · Iskidrop, Nimobrain
Luxembourg · Nimotop
Latvia · Nimotop
Netherlands · Nimotop
Norway · Nimotop
Portugal · Brainox, Modina
Romania · Nimotop
Sweden · Nimotop
Slovenia · Nimodipin Bayer, Nimodipin Laboratoire X.O
Slovakia · Dilceren Pro Infusione, Nemotan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c3db6105-b5eb-41b6-95e5-dfa80690224f
GET /v1/drugs/c3db6105-b5eb-41b6-95e5-dfa80690224f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "30 mg",
  "packaging": "05909991496494 ¦ Rp ¦ 146917\n20 tabl.\n05909991496500 ¦ Rp ¦ 146918\n50 tabl.\n05909991496517 ¦ Rp ¦ 146919\n100 tabl.",
  "substance": "Nimodipinum 30 mg",
  "common_name": "Nimodipinum",
  "pl_product_id": "100473592",
  "pozwolenie_nr": "357/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-09-26"
}

API reference MCP server Plans

See everything about nimodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console